Sangui BioTech International, Inc. is a holding company, which engages in the manufacture of wound treatment and cosmetic products. The company was founded in 1995 and is headquartered in Witten, Germany.
Company profile
Ticker
SGBI
Exchange
Website
CEO
Thomas Striepe
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
FELNAM INVESTMENTS INC
SEC CIK
Corporate docs
Subsidiaries
SanguiBioTech GmbH • Sangui Know-how- und Patentverwertungsgesellschaft mbH ...
IRS number
841330732
SGBI stock data
Latest filings (excl ownership)
10-Q
2023 Q3
Quarterly report
12 May 23
10-Q
2023 Q2
Quarterly report
7 Feb 23
10-Q
2023 Q1
Quarterly report
10 Nov 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
3 Nov 22
10-K
2022 FY
Annual report
28 Sep 22
10-Q
2022 Q3
Quarterly report
16 May 22
10-Q
2022 Q2
Quarterly report
11 Feb 22
10-Q
2022 Q1
Quarterly report
12 Nov 21
10-K
2021 FY
Annual report
28 Sep 21
UPLOAD
Letter from SEC
7 Jun 21
Latest ownership filings
Financial summary
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 22 | Jun 21 | Jun 20 | Jun 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |